VENT-02

N/A

Report date: 2025/10/30 20:00:05
NME

Base Information

Drug NameVENT-02
Drug Alias NameVENT-02
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsCentral nervous system modulators
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsNerve DegenerationNeuritisNeurodegenerative Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVentus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVentus Therapeutics Inc
Inactive CompaniesVentus Therapeutics US Inc
Active IndicationsNerve DegenerationNeuritis
Inactive IndicationsNeurodegenerative DiseasesParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A